These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1797197)

  • 1. Doxorubicin plus lonidamine: in vivo metabolic effects on the rat heart.
    Neri B; Lottini G; Bandinelli E; Cini-Neri G
    Anticancer Drugs; 1991 Aug; 2(4):401-4. PubMed ID: 1797197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects.
    Neri B; Cini-Neri G; Bandinelli M; Pacini P; Bartalucci S; Ciapini A
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):217-21. PubMed ID: 2737789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of L-carnitine on cardiac metabolic damage induced by doxorubicin in vitro.
    Neri B; Cini-Neri G; Bartalucci S; Bandinelli M
    Anticancer Res; 1986; 6(4):659-62. PubMed ID: 3752946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of oxygen uptake in vitro as an index of cardiac toxicity induced by new anthracyclines.
    Cini-Neri G; Neri B
    Anticancer Res; 1986; 6(2):195-7. PubMed ID: 3458425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin.
    Zupi G; Greco C; Laudonio N; Benassi M; Silvestrini B; Caputo A
    Anticancer Res; 1986; 6(5):1245-9. PubMed ID: 3800331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effect of lonidamine on the inhibition of mitochondrial respiration by adriamycin.
    Bagnato A; Bianchi C; Caputo A; Silvestrini B; Floridi A
    Anticancer Res; 1987; 7(4B):799-802. PubMed ID: 3674765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical determination of lonidamine in rat tissues and blood serum.
    Citro G; Galati R; Verdina A; Castiglione S; Silvestrini B; Caputo A; Floridi A
    Anticancer Res; 1989; 9(3):811-5. PubMed ID: 2669622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
    Koutinos G; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
    Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart.
    Briede J; Stivrina M; Vigante B; Stoldere D; Duburs G
    Cell Biochem Funct; 2008; 26(2):238-45. PubMed ID: 17990288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein ratios.
    Dorr RT; Bozak KA; Shipp NG; Hendrix M; Alberts DS; Ahmann F
    Cancer Res; 1988 Sep; 48(18):5222-7. PubMed ID: 3409247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes in the hearts of CD1 mice following chronic treatment with doxorubicin and lonidamine.
    Sanguedolce R; Flandina C; Cucchiara T; Varvara F; Rausa L
    Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):81-9. PubMed ID: 8272575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
    Colombo T; Zucchetti M; D'Incalci M
    J Pharmacol Exp Ther; 1994 Apr; 269(1):22-7. PubMed ID: 8169829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
    El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential changes in purine nucleotides after Doxorubicin treatment of human cancer cells in vitro.
    Walenta S; Feigk B; Wachsmuth I; Dunkern T; Degani H; Mueller-Klieser W
    Int J Oncol; 2002 Aug; 21(2):289-96. PubMed ID: 12118323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
    Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
    Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy metabolism of the heart in catecholamine-induced myocardial injury. Concentration-dependent effects of epinephrine on enzyme release, mechanical function, and "oxygen wastage".
    Horak AR; Opie LH
    Adv Myocardiol; 1983; 4():23-43. PubMed ID: 6304827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
    Giuliani F; Casazza AM; Di Marco A; Savi G
    Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats.
    Zhou S; Heller LJ; Wallace KB
    Toxicol Appl Pharmacol; 2001 Aug; 175(1):60-7. PubMed ID: 11509027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of radiation response of prostatic carcinoma by lonidamine.
    Dudak SD; Lopez A; Block NL; Lokeshwar BL
    Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of copper-based antineoplastic drugs casiopeinas is related to inhibition of energy metabolism.
    Hernández-Esquivel L; Marín-Hernández A; Pavón N; Carvajal K; Moreno-Sánchez R
    Toxicol Appl Pharmacol; 2006 Apr; 212(1):79-88. PubMed ID: 16051288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.